HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For Aim 2 of the trial:
- Adults aged 18 years or older
- People who have been diagnosed with Kaposi Sarcoma confirmed through a tissue sample test
- People who have at least 3 skin lesions from Kaposi Sarcoma
- People who are able to understand and agree to participate in the study
- People who are currently receiving treatment for Kaposi Sarcoma
For Aim 3 of the trial:
- Adults aged 18 years or older
- People who have been diagnosed with Kaposi Sarcoma confirmed through a tissue sample test
- People who are able to understand and agree to participate in the study
- People who are just starting treatment for Kaposi Sarcoma for the first time
Who may not be able to join:
For Aim 2 of the trial:
- People with Kaposi Sarcoma who are not yet starting or currently receiving treatment
- People who are very unwell and need to be cared for in a hospital
For Aim 3 of the trial:
- People with Kaposi Sarcoma who already took part in Aim 1 or Aim 2 of this trial
- People who have previously received or are currently receiving treatment for Kaposi Sarcoma
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Thomas Odeny, MBChB, MPH, PhD, Washington University School of Medicine
Phone: 314-273-3022
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Reproducibility of KS lesion size measurements between SkinScan3D and current standard of care measurement - Aim 2 Only; Accuracy of KS lesion size measurements between SkinScan3D and current standard of care measurement - Aim 2 Only; Device usability - Aim 3 Only; Acceptability - Aim 3 Only; Appropriateness - Aim 3 Only; Feasibility - Aim 3 Only
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.